BUPROPION HYDROCHLORIDE
- Product NDC
- 55700-849
- 11-digit product format
- 557000849
- Labeler code
- 55700
- Product ID
- 55700-849_50d97375-a844-4a40-bb4c-a14841d42684
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUPROPION HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Quality Care Products, LLC
- Application
- ANDA210497
- Marketing category
- ANDA
- Marketing start
- 2020-03-16
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55700-849 | BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [QUALITY CARE PRODUCTS, LLC] | 3 | Legacy NDC | 20241220_5301bc62-888a-4151-8938-d61f0e52bb45.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55700-849-30 | 55700084930 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55700-849-30) | 2020-03-16 | 0000-00-00 | No | No | Current |